Effects of tolvaptan in the early postoperative stage after heart valve surgery: results of the STAR (Study of Tolvaptan for fluid retention AfteR valve surgery) trial-Reference-Cited by-同舟云学术

Effects of tolvaptan in the early postoperative stage after heart valve surgery: results of the STAR (Study of Tolvaptan for fluid retention AfteR valve surgery) trial

Published:2015-09-28 Issue:12 Volume:45 Page:1542-1551
ISSN:0941-1291
Container-title:Surgery Today
language:en
Short-container-title:Surg Today

Author:

Nishi Hiroyuki,Toda Koichi,Miyagawa Shigeru,Yoshikawa Yasushi,Fukushima Satsuki,Kawamura Masashi,Yoshioka Daisuke,Saito Tetsuya,Ueno Takayoshi,Kuratani Toru,Sawa Yoshiki

Publisher

Springer Science and Business Media LLC

Subject

General Medicine,Surgery

Link

http://link.springer.com/content/pdf/10.1007/s00595-015-1251-y.pdf

Reference27 articles.

1. Gandhi A, Husain M, Salhiyyah K, Raja SG. Does perioperative furosemide usage reduce the need for renal replacement therapy in cardiac surgery patients? Interact CardioVasc Thorac Surg. 2012;15:750–5.

2. Sirivella S, Gielchinsky I, Parsonnet V. Mannitol, furosemide, and dopamine infusion in postoperative renal failure complicating cardiac surgery. Ann Thorac Surg. 2000;69:501–6.

3. Sezai A, Hata M, Niino T, Yoshitake I, Unosawa S, Wakui S, et al. Results of low-dose human atrial natriuretic peptide infusion in nondialysis patients with chronic kidney disease undergoing coronary artery bypass grafting: the NU-HIT (Nihon University working group study of low-dose HANP Infusion Therapy during cardiac surgery) trial for CKD. J Am Coll Cardiol. 2011;58:897–903.

4. Sica D, Oren RM, Gottwald MD. Mills RM; Scios 351 Investigators. Natriuretic and neurohormonal responses to nesiritide, furosemide, and combined nesiritide and furosemide in patients with stable systolic dysfunction. Clin Cardiol. 2010;33:330–6.

5. Felker GM, Lee KL, Bull DA, Redfield MM, Stevenson LW, Goldsmith SR, et al. Diuretic strategies in patients with acute decompensated heart failure. N Engl J Med. 2011;364:797–805.

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of tolvaptan in postoperative volume therapy for acute Stanford type A aortic dissection;BMC Cardiovascular Disorders;2023-02-21

2. Effects of Low-Dose Tolvaptan for Fluid Management After Cardiovascular Surgery;Circulation Reports;2022-12-09

3. Peak Lag Between Plasma Vasopressin and Urine Aquaporin-2 Following Cardiac Surgery;International Heart Journal;2021-09-29

4. The Efficacy and Renal Protective Effect of Tolvaptan in Chronic Kidney Disease Patients after Open-Heart Surgery;Annals of Thoracic and Cardiovascular Surgery;2021

5. Efficacy of tolvaptan for fluid management after cardiovascular surgery: A systematic review and meta‑analysis of randomized control trials;Experimental and Therapeutic Medicine;2020-07-13